Global Outsourced Drug Discovery

Outsourced Drug Discovery Comprehensive Study by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology, Others), Services (Preclinical Developments, Target validation and Functional Informatics, Target Identification and Screening, Lead Identification and Candidate Optimization, Others), Out sourcing Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), End-User (Pharmaceutical and Biotechnological Companies, Contract Research Organization, Contract Manufacturing Organization) Players and Region - Global Market Outlook to 2030

Outsourced Drug Discovery Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Outsourced Drug Discovery Market Scope
The pharmaceutical companies are progressively outsourcing research activities to private and academic contract research organizations (CROs) as a method to stay competitive and flexible in exponentially growing knowledge, gradually refined technologies and an uneven economic environment. It is getting more expensive to develop new drugs, competition from generics is increasing, investors expect double-digit growth, complaints from consumers and payers about excessive drug prices are more strident, and the number of new drugs reaching the market each year is below expectations.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledCharles River (United States), EVOTEC (Germany), Laboratory Corporation of America Holdings (United States), GenScript, Merck & Co., Inc. (United States), Thermo Fisher Scientific, Inc. (United States), Oncodesign (France), Albany Molecular Research, Inc. (United States), Dalton Pharma Services (Canada), Pharmaceutical Product Development, LLC (United States), DiscoverX Corporation (United States), Bioduro LLC (United States) and Syngene International Ltd. (India)
CAGR7.6%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Outsourced Drug Discovery market throughout the predicted period.

Charles River (United States), EVOTEC (Germany), Laboratory Corporation of America Holdings (United States), GenScript, Merck & Co., Inc. (United States), Thermo Fisher Scientific, Inc. (United States), Oncodesign (France), Albany Molecular Research, Inc. (United States), Dalton Pharma Services (Canada), Pharmaceutical Product Development, LLC (United States), DiscoverX Corporation (United States), Bioduro LLC (United States) and Syngene International Ltd. (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Sundia Meditech Co. Ltd. (China) and WuXi AppTec (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Outsourced Drug Discovery market by Type , by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology and Others) and Region with country level break-up.

On the basis of geography, the market of Outsourced Drug Discovery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In January 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. entered into a collaboration agreement with Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and development company to advance the discovery and development of drugs targeting a number of different targets globally through the use of AI technology.
In December 2023, Merck launched its AIDDISON™ drug discovery software. This software-as-a-service platform integrates virtual molecule design with real-world manufacturability through Synthia™ retrosynthesis software application programming interface (API) integration.


Influencing Trend:
Increasing Trend of Outsourcing Manufacturing and R&D Activities to Countries such as China and India and Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology

Market Growth Drivers:
Growing Number of CRO, CMOs, and CDMOs in Emerging Countries and Rising Demand for the Biological Drugs

Challenges:
Unknown Regulation Complications and Duplication Problems

Restraints:
High Capital Investment for the Drug Discovery Settings

Opportunities:
Rising Demand of Small Molecule Drugs for Treating Chronic Diseases and Increasing Healthcare Expenditure in the Developing Economies

Key Target Audience
Drug Discovery Outsourced Providers, Pharmaceutical Industry, Biotechnological Companies, Governmental Bodies, Downstream Vendors and Others

Report Objectives / Segmentation Covered

By Application
  • Oncology
  • Ophthalmology
  • Hematology
  • Immunomodulation
  • Anti-Infective Drugs
  • Dermatology
  • Neurology
  • Cardiology
  • Others
By Services
  • Preclinical Developments
  • Target validation and Functional Informatics
  • Target Identification and Screening
  • Lead Identification and Candidate Optimization
  • Others

By Out sourcing Drug Type
  • Small Molecules
  • Large Molecules (Biopharmaceuticals)

By End-User
  • Pharmaceutical and Biotechnological Companies
  • Contract Research Organization
  • Contract Manufacturing Organization

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of CRO, CMOs, and CDMOs in Emerging Countries
      • 3.2.2. Rising Demand for the Biological Drugs
    • 3.3. Market Challenges
      • 3.3.1. Unknown Regulation Complications and Duplication Problems
    • 3.4. Market Trends
      • 3.4.1. Increasing Trend of Outsourcing Manufacturing and R&D Activities to Countries such as China and India
      • 3.4.2. Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Outsourced Drug Discovery, by Application, Services, Out sourcing Drug Type, End-User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Outsourced Drug Discovery (Value)
      • 5.2.1. Global Outsourced Drug Discovery by: Application (Value)
        • 5.2.1.1. Oncology
        • 5.2.1.2. Ophthalmology
        • 5.2.1.3. Hematology
        • 5.2.1.4. Immunomodulation
        • 5.2.1.5. Anti-Infective Drugs
        • 5.2.1.6. Dermatology
        • 5.2.1.7. Neurology
        • 5.2.1.8. Cardiology
        • 5.2.1.9. Others
      • 5.2.2. Global Outsourced Drug Discovery by: Services (Value)
        • 5.2.2.1. Preclinical Developments
        • 5.2.2.2. Target validation and Functional Informatics
        • 5.2.2.3. Target Identification and Screening
        • 5.2.2.4. Lead Identification and Candidate Optimization
        • 5.2.2.5. Others
      • 5.2.3. Global Outsourced Drug Discovery by: Out sourcing Drug Type (Value)
        • 5.2.3.1. Small Molecules
        • 5.2.3.2. Large Molecules (Biopharmaceuticals)
      • 5.2.4. Global Outsourced Drug Discovery by: End-User (Value)
        • 5.2.4.1. Pharmaceutical and Biotechnological Companies
        • 5.2.4.2. Contract Research Organization
        • 5.2.4.3. Contract Manufacturing Organization
      • 5.2.5. Global Outsourced Drug Discovery Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Outsourced Drug Discovery (Volume)
      • 5.3.1. Global Outsourced Drug Discovery by: Application (Volume)
        • 5.3.1.1. Oncology
        • 5.3.1.2. Ophthalmology
        • 5.3.1.3. Hematology
        • 5.3.1.4. Immunomodulation
        • 5.3.1.5. Anti-Infective Drugs
        • 5.3.1.6. Dermatology
        • 5.3.1.7. Neurology
        • 5.3.1.8. Cardiology
        • 5.3.1.9. Others
      • 5.3.2. Global Outsourced Drug Discovery by: Services (Volume)
        • 5.3.2.1. Preclinical Developments
        • 5.3.2.2. Target validation and Functional Informatics
        • 5.3.2.3. Target Identification and Screening
        • 5.3.2.4. Lead Identification and Candidate Optimization
        • 5.3.2.5. Others
      • 5.3.3. Global Outsourced Drug Discovery by: Out sourcing Drug Type (Volume)
        • 5.3.3.1. Small Molecules
        • 5.3.3.2. Large Molecules (Biopharmaceuticals)
      • 5.3.4. Global Outsourced Drug Discovery by: End-User (Volume)
        • 5.3.4.1. Pharmaceutical and Biotechnological Companies
        • 5.3.4.2. Contract Research Organization
        • 5.3.4.3. Contract Manufacturing Organization
      • 5.3.5. Global Outsourced Drug Discovery Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Outsourced Drug Discovery (Price)
  • 6. Outsourced Drug Discovery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Charles River (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. EVOTEC (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Laboratory Corporation of America Holdings (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GenScript, Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Oncodesign (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Albany Molecular Research, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Dalton Pharma Services (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pharmaceutical Product Development, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. DiscoverX Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bioduro LLC (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Syngene International Ltd. (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Outsourced Drug Discovery Sale, by Application, Services, Out sourcing Drug Type, End-User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Outsourced Drug Discovery (Value)
      • 7.2.1. Global Outsourced Drug Discovery by: Application (Value)
        • 7.2.1.1. Oncology
        • 7.2.1.2. Ophthalmology
        • 7.2.1.3. Hematology
        • 7.2.1.4. Immunomodulation
        • 7.2.1.5. Anti-Infective Drugs
        • 7.2.1.6. Dermatology
        • 7.2.1.7. Neurology
        • 7.2.1.8. Cardiology
        • 7.2.1.9. Others
      • 7.2.2. Global Outsourced Drug Discovery by: Services (Value)
        • 7.2.2.1. Preclinical Developments
        • 7.2.2.2. Target validation and Functional Informatics
        • 7.2.2.3. Target Identification and Screening
        • 7.2.2.4. Lead Identification and Candidate Optimization
        • 7.2.2.5. Others
      • 7.2.3. Global Outsourced Drug Discovery by: Out sourcing Drug Type (Value)
        • 7.2.3.1. Small Molecules
        • 7.2.3.2. Large Molecules (Biopharmaceuticals)
      • 7.2.4. Global Outsourced Drug Discovery by: End-User (Value)
        • 7.2.4.1. Pharmaceutical and Biotechnological Companies
        • 7.2.4.2. Contract Research Organization
        • 7.2.4.3. Contract Manufacturing Organization
      • 7.2.5. Global Outsourced Drug Discovery Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Outsourced Drug Discovery (Volume)
      • 7.3.1. Global Outsourced Drug Discovery by: Application (Volume)
        • 7.3.1.1. Oncology
        • 7.3.1.2. Ophthalmology
        • 7.3.1.3. Hematology
        • 7.3.1.4. Immunomodulation
        • 7.3.1.5. Anti-Infective Drugs
        • 7.3.1.6. Dermatology
        • 7.3.1.7. Neurology
        • 7.3.1.8. Cardiology
        • 7.3.1.9. Others
      • 7.3.2. Global Outsourced Drug Discovery by: Services (Volume)
        • 7.3.2.1. Preclinical Developments
        • 7.3.2.2. Target validation and Functional Informatics
        • 7.3.2.3. Target Identification and Screening
        • 7.3.2.4. Lead Identification and Candidate Optimization
        • 7.3.2.5. Others
      • 7.3.3. Global Outsourced Drug Discovery by: Out sourcing Drug Type (Volume)
        • 7.3.3.1. Small Molecules
        • 7.3.3.2. Large Molecules (Biopharmaceuticals)
      • 7.3.4. Global Outsourced Drug Discovery by: End-User (Volume)
        • 7.3.4.1. Pharmaceutical and Biotechnological Companies
        • 7.3.4.2. Contract Research Organization
        • 7.3.4.3. Contract Manufacturing Organization
      • 7.3.5. Global Outsourced Drug Discovery Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Outsourced Drug Discovery (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Outsourced Drug Discovery: by Application(USD Million)
  • Table 2. Outsourced Drug Discovery Oncology , by Region USD Million (2018-2023)
  • Table 3. Outsourced Drug Discovery Ophthalmology , by Region USD Million (2018-2023)
  • Table 4. Outsourced Drug Discovery Hematology , by Region USD Million (2018-2023)
  • Table 5. Outsourced Drug Discovery Immunomodulation , by Region USD Million (2018-2023)
  • Table 6. Outsourced Drug Discovery Anti-Infective Drugs , by Region USD Million (2018-2023)
  • Table 7. Outsourced Drug Discovery Dermatology , by Region USD Million (2018-2023)
  • Table 8. Outsourced Drug Discovery Neurology , by Region USD Million (2018-2023)
  • Table 9. Outsourced Drug Discovery Cardiology , by Region USD Million (2018-2023)
  • Table 10. Outsourced Drug Discovery Others , by Region USD Million (2018-2023)
  • Table 11. Outsourced Drug Discovery: by Services(USD Million)
  • Table 12. Outsourced Drug Discovery Preclinical Developments , by Region USD Million (2018-2023)
  • Table 13. Outsourced Drug Discovery Target validation and Functional Informatics , by Region USD Million (2018-2023)
  • Table 14. Outsourced Drug Discovery Target Identification and Screening , by Region USD Million (2018-2023)
  • Table 15. Outsourced Drug Discovery Lead Identification and Candidate Optimization , by Region USD Million (2018-2023)
  • Table 16. Outsourced Drug Discovery Others , by Region USD Million (2018-2023)
  • Table 17. Outsourced Drug Discovery: by Out sourcing Drug Type(USD Million)
  • Table 18. Outsourced Drug Discovery Small Molecules , by Region USD Million (2018-2023)
  • Table 19. Outsourced Drug Discovery Large Molecules (Biopharmaceuticals) , by Region USD Million (2018-2023)
  • Table 20. Outsourced Drug Discovery: by End-User(USD Million)
  • Table 21. Outsourced Drug Discovery Pharmaceutical and Biotechnological Companies , by Region USD Million (2018-2023)
  • Table 22. Outsourced Drug Discovery Contract Research Organization , by Region USD Million (2018-2023)
  • Table 23. Outsourced Drug Discovery Contract Manufacturing Organization , by Region USD Million (2018-2023)
  • Table 24. South America Outsourced Drug Discovery, by Country USD Million (2018-2023)
  • Table 25. South America Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 26. South America Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 27. South America Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 28. South America Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 29. Brazil Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 30. Brazil Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 31. Brazil Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 32. Brazil Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 33. Argentina Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 34. Argentina Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 35. Argentina Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 36. Argentina Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 37. Rest of South America Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 38. Rest of South America Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 39. Rest of South America Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 40. Rest of South America Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 41. Asia Pacific Outsourced Drug Discovery, by Country USD Million (2018-2023)
  • Table 42. Asia Pacific Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 43. Asia Pacific Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 44. Asia Pacific Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 45. Asia Pacific Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 46. China Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 47. China Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 48. China Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 49. China Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 50. Japan Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 51. Japan Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 52. Japan Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 53. Japan Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 54. India Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 55. India Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 56. India Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 57. India Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 58. South Korea Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 59. South Korea Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 60. South Korea Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 61. South Korea Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 62. Taiwan Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 63. Taiwan Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 64. Taiwan Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 65. Taiwan Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 66. Australia Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 67. Australia Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 68. Australia Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 69. Australia Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 74. Europe Outsourced Drug Discovery, by Country USD Million (2018-2023)
  • Table 75. Europe Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 76. Europe Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 77. Europe Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 78. Europe Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 79. Germany Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 80. Germany Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 81. Germany Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 82. Germany Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 83. France Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 84. France Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 85. France Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 86. France Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 87. Italy Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 88. Italy Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 89. Italy Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 90. Italy Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 91. United Kingdom Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 92. United Kingdom Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 93. United Kingdom Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 94. United Kingdom Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 95. Netherlands Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 96. Netherlands Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 97. Netherlands Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 98. Netherlands Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 99. Rest of Europe Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 100. Rest of Europe Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 101. Rest of Europe Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 102. Rest of Europe Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 103. MEA Outsourced Drug Discovery, by Country USD Million (2018-2023)
  • Table 104. MEA Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 105. MEA Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 106. MEA Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 107. MEA Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 108. Middle East Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 109. Middle East Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 110. Middle East Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 111. Middle East Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 112. Africa Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 113. Africa Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 114. Africa Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 115. Africa Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 116. North America Outsourced Drug Discovery, by Country USD Million (2018-2023)
  • Table 117. North America Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 118. North America Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 119. North America Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 120. North America Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 121. United States Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 122. United States Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 123. United States Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 124. United States Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 125. Canada Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 126. Canada Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 127. Canada Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 128. Canada Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 129. Mexico Outsourced Drug Discovery, by Application USD Million (2018-2023)
  • Table 130. Mexico Outsourced Drug Discovery, by Services USD Million (2018-2023)
  • Table 131. Mexico Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2018-2023)
  • Table 132. Mexico Outsourced Drug Discovery, by End-User USD Million (2018-2023)
  • Table 133. Outsourced Drug Discovery Sales: by Application(K Tons)
  • Table 134. Outsourced Drug Discovery Sales Oncology , by Region K Tons (2018-2023)
  • Table 135. Outsourced Drug Discovery Sales Ophthalmology , by Region K Tons (2018-2023)
  • Table 136. Outsourced Drug Discovery Sales Hematology , by Region K Tons (2018-2023)
  • Table 137. Outsourced Drug Discovery Sales Immunomodulation , by Region K Tons (2018-2023)
  • Table 138. Outsourced Drug Discovery Sales Anti-Infective Drugs , by Region K Tons (2018-2023)
  • Table 139. Outsourced Drug Discovery Sales Dermatology , by Region K Tons (2018-2023)
  • Table 140. Outsourced Drug Discovery Sales Neurology , by Region K Tons (2018-2023)
  • Table 141. Outsourced Drug Discovery Sales Cardiology , by Region K Tons (2018-2023)
  • Table 142. Outsourced Drug Discovery Sales Others , by Region K Tons (2018-2023)
  • Table 143. Outsourced Drug Discovery Sales: by Services(K Tons)
  • Table 144. Outsourced Drug Discovery Sales Preclinical Developments , by Region K Tons (2018-2023)
  • Table 145. Outsourced Drug Discovery Sales Target validation and Functional Informatics , by Region K Tons (2018-2023)
  • Table 146. Outsourced Drug Discovery Sales Target Identification and Screening , by Region K Tons (2018-2023)
  • Table 147. Outsourced Drug Discovery Sales Lead Identification and Candidate Optimization , by Region K Tons (2018-2023)
  • Table 148. Outsourced Drug Discovery Sales Others , by Region K Tons (2018-2023)
  • Table 149. Outsourced Drug Discovery Sales: by Out sourcing Drug Type(K Tons)
  • Table 150. Outsourced Drug Discovery Sales Small Molecules , by Region K Tons (2018-2023)
  • Table 151. Outsourced Drug Discovery Sales Large Molecules (Biopharmaceuticals) , by Region K Tons (2018-2023)
  • Table 152. Outsourced Drug Discovery Sales: by End-User(K Tons)
  • Table 153. Outsourced Drug Discovery Sales Pharmaceutical and Biotechnological Companies , by Region K Tons (2018-2023)
  • Table 154. Outsourced Drug Discovery Sales Contract Research Organization , by Region K Tons (2018-2023)
  • Table 155. Outsourced Drug Discovery Sales Contract Manufacturing Organization , by Region K Tons (2018-2023)
  • Table 156. South America Outsourced Drug Discovery Sales, by Country K Tons (2018-2023)
  • Table 157. South America Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 158. South America Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 159. South America Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 160. South America Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 161. Brazil Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 162. Brazil Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 163. Brazil Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 164. Brazil Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 165. Argentina Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 166. Argentina Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 167. Argentina Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 168. Argentina Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 169. Rest of South America Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 170. Rest of South America Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 171. Rest of South America Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 172. Rest of South America Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 173. Asia Pacific Outsourced Drug Discovery Sales, by Country K Tons (2018-2023)
  • Table 174. Asia Pacific Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 175. Asia Pacific Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 176. Asia Pacific Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 177. Asia Pacific Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 178. China Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 179. China Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 180. China Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 181. China Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 182. Japan Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 183. Japan Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 184. Japan Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 185. Japan Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 186. India Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 187. India Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 188. India Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 189. India Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 190. South Korea Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 191. South Korea Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 192. South Korea Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 193. South Korea Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 194. Taiwan Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 195. Taiwan Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 196. Taiwan Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 197. Taiwan Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 198. Australia Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 199. Australia Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 200. Australia Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 201. Australia Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 202. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 203. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 204. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 205. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 206. Europe Outsourced Drug Discovery Sales, by Country K Tons (2018-2023)
  • Table 207. Europe Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 208. Europe Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 209. Europe Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 210. Europe Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 211. Germany Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 212. Germany Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 213. Germany Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 214. Germany Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 215. France Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 216. France Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 217. France Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 218. France Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 219. Italy Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 220. Italy Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 221. Italy Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 222. Italy Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 223. United Kingdom Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 224. United Kingdom Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 225. United Kingdom Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 226. United Kingdom Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 227. Netherlands Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 228. Netherlands Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 229. Netherlands Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 230. Netherlands Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 231. Rest of Europe Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 232. Rest of Europe Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 233. Rest of Europe Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 234. Rest of Europe Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 235. MEA Outsourced Drug Discovery Sales, by Country K Tons (2018-2023)
  • Table 236. MEA Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 237. MEA Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 238. MEA Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 239. MEA Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 240. Middle East Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 241. Middle East Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 242. Middle East Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 243. Middle East Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 244. Africa Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 245. Africa Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 246. Africa Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 247. Africa Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 248. North America Outsourced Drug Discovery Sales, by Country K Tons (2018-2023)
  • Table 249. North America Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 250. North America Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 251. North America Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 252. North America Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 253. United States Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 254. United States Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 255. United States Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 256. United States Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 257. Canada Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 258. Canada Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 259. Canada Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 260. Canada Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 261. Mexico Outsourced Drug Discovery Sales, by Application K Tons (2018-2023)
  • Table 262. Mexico Outsourced Drug Discovery Sales, by Services K Tons (2018-2023)
  • Table 263. Mexico Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2018-2023)
  • Table 264. Mexico Outsourced Drug Discovery Sales, by End-User K Tons (2018-2023)
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Company Basic Information, Sales Area and Its Competitors
  • Table 277. Outsourced Drug Discovery: by Application(USD Million)
  • Table 278. Outsourced Drug Discovery Oncology , by Region USD Million (2025-2030)
  • Table 279. Outsourced Drug Discovery Ophthalmology , by Region USD Million (2025-2030)
  • Table 280. Outsourced Drug Discovery Hematology , by Region USD Million (2025-2030)
  • Table 281. Outsourced Drug Discovery Immunomodulation , by Region USD Million (2025-2030)
  • Table 282. Outsourced Drug Discovery Anti-Infective Drugs , by Region USD Million (2025-2030)
  • Table 283. Outsourced Drug Discovery Dermatology , by Region USD Million (2025-2030)
  • Table 284. Outsourced Drug Discovery Neurology , by Region USD Million (2025-2030)
  • Table 285. Outsourced Drug Discovery Cardiology , by Region USD Million (2025-2030)
  • Table 286. Outsourced Drug Discovery Others , by Region USD Million (2025-2030)
  • Table 287. Outsourced Drug Discovery: by Services(USD Million)
  • Table 288. Outsourced Drug Discovery Preclinical Developments , by Region USD Million (2025-2030)
  • Table 289. Outsourced Drug Discovery Target validation and Functional Informatics , by Region USD Million (2025-2030)
  • Table 290. Outsourced Drug Discovery Target Identification and Screening , by Region USD Million (2025-2030)
  • Table 291. Outsourced Drug Discovery Lead Identification and Candidate Optimization , by Region USD Million (2025-2030)
  • Table 292. Outsourced Drug Discovery Others , by Region USD Million (2025-2030)
  • Table 293. Outsourced Drug Discovery: by Out sourcing Drug Type(USD Million)
  • Table 294. Outsourced Drug Discovery Small Molecules , by Region USD Million (2025-2030)
  • Table 295. Outsourced Drug Discovery Large Molecules (Biopharmaceuticals) , by Region USD Million (2025-2030)
  • Table 296. Outsourced Drug Discovery: by End-User(USD Million)
  • Table 297. Outsourced Drug Discovery Pharmaceutical and Biotechnological Companies , by Region USD Million (2025-2030)
  • Table 298. Outsourced Drug Discovery Contract Research Organization , by Region USD Million (2025-2030)
  • Table 299. Outsourced Drug Discovery Contract Manufacturing Organization , by Region USD Million (2025-2030)
  • Table 300. South America Outsourced Drug Discovery, by Country USD Million (2025-2030)
  • Table 301. South America Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 302. South America Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 303. South America Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 304. South America Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 305. Brazil Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 306. Brazil Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 307. Brazil Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 308. Brazil Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 309. Argentina Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 310. Argentina Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 311. Argentina Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 312. Argentina Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 313. Rest of South America Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 314. Rest of South America Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 315. Rest of South America Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 316. Rest of South America Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 317. Asia Pacific Outsourced Drug Discovery, by Country USD Million (2025-2030)
  • Table 318. Asia Pacific Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 319. Asia Pacific Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 320. Asia Pacific Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 321. Asia Pacific Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 322. China Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 323. China Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 324. China Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 325. China Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 326. Japan Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 327. Japan Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 328. Japan Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 329. Japan Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 330. India Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 331. India Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 332. India Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 333. India Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 334. South Korea Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 335. South Korea Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 336. South Korea Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 337. South Korea Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 338. Taiwan Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 339. Taiwan Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 340. Taiwan Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 341. Taiwan Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 342. Australia Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 343. Australia Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 344. Australia Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 345. Australia Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 346. Rest of Asia-Pacific Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 347. Rest of Asia-Pacific Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 348. Rest of Asia-Pacific Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 349. Rest of Asia-Pacific Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 350. Europe Outsourced Drug Discovery, by Country USD Million (2025-2030)
  • Table 351. Europe Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 352. Europe Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 353. Europe Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 354. Europe Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 355. Germany Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 356. Germany Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 357. Germany Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 358. Germany Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 359. France Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 360. France Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 361. France Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 362. France Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 363. Italy Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 364. Italy Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 365. Italy Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 366. Italy Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 367. United Kingdom Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 368. United Kingdom Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 369. United Kingdom Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 370. United Kingdom Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 371. Netherlands Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 372. Netherlands Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 373. Netherlands Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 374. Netherlands Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 375. Rest of Europe Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 376. Rest of Europe Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 377. Rest of Europe Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 378. Rest of Europe Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 379. MEA Outsourced Drug Discovery, by Country USD Million (2025-2030)
  • Table 380. MEA Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 381. MEA Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 382. MEA Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 383. MEA Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 384. Middle East Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 385. Middle East Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 386. Middle East Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 387. Middle East Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 388. Africa Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 389. Africa Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 390. Africa Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 391. Africa Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 392. North America Outsourced Drug Discovery, by Country USD Million (2025-2030)
  • Table 393. North America Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 394. North America Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 395. North America Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 396. North America Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 397. United States Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 398. United States Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 399. United States Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 400. United States Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 401. Canada Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 402. Canada Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 403. Canada Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 404. Canada Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 405. Mexico Outsourced Drug Discovery, by Application USD Million (2025-2030)
  • Table 406. Mexico Outsourced Drug Discovery, by Services USD Million (2025-2030)
  • Table 407. Mexico Outsourced Drug Discovery, by Out sourcing Drug Type USD Million (2025-2030)
  • Table 408. Mexico Outsourced Drug Discovery, by End-User USD Million (2025-2030)
  • Table 409. Outsourced Drug Discovery Sales: by Application(K Tons)
  • Table 410. Outsourced Drug Discovery Sales Oncology , by Region K Tons (2025-2030)
  • Table 411. Outsourced Drug Discovery Sales Ophthalmology , by Region K Tons (2025-2030)
  • Table 412. Outsourced Drug Discovery Sales Hematology , by Region K Tons (2025-2030)
  • Table 413. Outsourced Drug Discovery Sales Immunomodulation , by Region K Tons (2025-2030)
  • Table 414. Outsourced Drug Discovery Sales Anti-Infective Drugs , by Region K Tons (2025-2030)
  • Table 415. Outsourced Drug Discovery Sales Dermatology , by Region K Tons (2025-2030)
  • Table 416. Outsourced Drug Discovery Sales Neurology , by Region K Tons (2025-2030)
  • Table 417. Outsourced Drug Discovery Sales Cardiology , by Region K Tons (2025-2030)
  • Table 418. Outsourced Drug Discovery Sales Others , by Region K Tons (2025-2030)
  • Table 419. Outsourced Drug Discovery Sales: by Services(K Tons)
  • Table 420. Outsourced Drug Discovery Sales Preclinical Developments , by Region K Tons (2025-2030)
  • Table 421. Outsourced Drug Discovery Sales Target validation and Functional Informatics , by Region K Tons (2025-2030)
  • Table 422. Outsourced Drug Discovery Sales Target Identification and Screening , by Region K Tons (2025-2030)
  • Table 423. Outsourced Drug Discovery Sales Lead Identification and Candidate Optimization , by Region K Tons (2025-2030)
  • Table 424. Outsourced Drug Discovery Sales Others , by Region K Tons (2025-2030)
  • Table 425. Outsourced Drug Discovery Sales: by Out sourcing Drug Type(K Tons)
  • Table 426. Outsourced Drug Discovery Sales Small Molecules , by Region K Tons (2025-2030)
  • Table 427. Outsourced Drug Discovery Sales Large Molecules (Biopharmaceuticals) , by Region K Tons (2025-2030)
  • Table 428. Outsourced Drug Discovery Sales: by End-User(K Tons)
  • Table 429. Outsourced Drug Discovery Sales Pharmaceutical and Biotechnological Companies , by Region K Tons (2025-2030)
  • Table 430. Outsourced Drug Discovery Sales Contract Research Organization , by Region K Tons (2025-2030)
  • Table 431. Outsourced Drug Discovery Sales Contract Manufacturing Organization , by Region K Tons (2025-2030)
  • Table 432. South America Outsourced Drug Discovery Sales, by Country K Tons (2025-2030)
  • Table 433. South America Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 434. South America Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 435. South America Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 436. South America Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 437. Brazil Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 438. Brazil Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 439. Brazil Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 440. Brazil Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 441. Argentina Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 442. Argentina Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 443. Argentina Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 444. Argentina Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 445. Rest of South America Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 446. Rest of South America Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 447. Rest of South America Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 448. Rest of South America Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 449. Asia Pacific Outsourced Drug Discovery Sales, by Country K Tons (2025-2030)
  • Table 450. Asia Pacific Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 451. Asia Pacific Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 452. Asia Pacific Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 453. Asia Pacific Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 454. China Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 455. China Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 456. China Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 457. China Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 458. Japan Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 459. Japan Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 460. Japan Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 461. Japan Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 462. India Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 463. India Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 464. India Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 465. India Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 466. South Korea Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 467. South Korea Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 468. South Korea Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 469. South Korea Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 470. Taiwan Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 471. Taiwan Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 472. Taiwan Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 473. Taiwan Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 474. Australia Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 475. Australia Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 476. Australia Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 477. Australia Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 478. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 479. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 480. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 481. Rest of Asia-Pacific Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 482. Europe Outsourced Drug Discovery Sales, by Country K Tons (2025-2030)
  • Table 483. Europe Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 484. Europe Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 485. Europe Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 486. Europe Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 487. Germany Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 488. Germany Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 489. Germany Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 490. Germany Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 491. France Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 492. France Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 493. France Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 494. France Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 495. Italy Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 496. Italy Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 497. Italy Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 498. Italy Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 499. United Kingdom Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 500. United Kingdom Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 501. United Kingdom Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 502. United Kingdom Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 503. Netherlands Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 504. Netherlands Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 505. Netherlands Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 506. Netherlands Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 507. Rest of Europe Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 508. Rest of Europe Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 509. Rest of Europe Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 510. Rest of Europe Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 511. MEA Outsourced Drug Discovery Sales, by Country K Tons (2025-2030)
  • Table 512. MEA Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 513. MEA Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 514. MEA Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 515. MEA Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 516. Middle East Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 517. Middle East Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 518. Middle East Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 519. Middle East Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 520. Africa Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 521. Africa Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 522. Africa Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 523. Africa Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 524. North America Outsourced Drug Discovery Sales, by Country K Tons (2025-2030)
  • Table 525. North America Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 526. North America Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 527. North America Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 528. North America Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 529. United States Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 530. United States Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 531. United States Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 532. United States Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 533. Canada Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 534. Canada Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 535. Canada Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 536. Canada Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 537. Mexico Outsourced Drug Discovery Sales, by Application K Tons (2025-2030)
  • Table 538. Mexico Outsourced Drug Discovery Sales, by Services K Tons (2025-2030)
  • Table 539. Mexico Outsourced Drug Discovery Sales, by Out sourcing Drug Type K Tons (2025-2030)
  • Table 540. Mexico Outsourced Drug Discovery Sales, by End-User K Tons (2025-2030)
  • Table 541. Research Programs/Design for This Report
  • Table 542. Key Data Information from Secondary Sources
  • Table 543. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Outsourced Drug Discovery: by Application USD Million (2018-2023)
  • Figure 5. Global Outsourced Drug Discovery: by Services USD Million (2018-2023)
  • Figure 6. Global Outsourced Drug Discovery: by Out sourcing Drug Type USD Million (2018-2023)
  • Figure 7. Global Outsourced Drug Discovery: by End-User USD Million (2018-2023)
  • Figure 8. South America Outsourced Drug Discovery Share (%), by Country
  • Figure 9. Asia Pacific Outsourced Drug Discovery Share (%), by Country
  • Figure 10. Europe Outsourced Drug Discovery Share (%), by Country
  • Figure 11. MEA Outsourced Drug Discovery Share (%), by Country
  • Figure 12. North America Outsourced Drug Discovery Share (%), by Country
  • Figure 13. Global Outsourced Drug Discovery: by Application K Tons (2018-2023)
  • Figure 14. Global Outsourced Drug Discovery: by Services K Tons (2018-2023)
  • Figure 15. Global Outsourced Drug Discovery: by Out sourcing Drug Type K Tons (2018-2023)
  • Figure 16. Global Outsourced Drug Discovery: by End-User K Tons (2018-2023)
  • Figure 17. South America Outsourced Drug Discovery Share (%), by Country
  • Figure 18. Asia Pacific Outsourced Drug Discovery Share (%), by Country
  • Figure 19. Europe Outsourced Drug Discovery Share (%), by Country
  • Figure 20. MEA Outsourced Drug Discovery Share (%), by Country
  • Figure 21. North America Outsourced Drug Discovery Share (%), by Country
  • Figure 22. Global Outsourced Drug Discovery share by Players 2023 (%)
  • Figure 23. Global Outsourced Drug Discovery share by Players (Top 3) 2023(%)
  • Figure 24. Global Outsourced Drug Discovery share by Players (Top 5) 2023(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Charles River (United States) Revenue, Net Income and Gross profit
  • Figure 27. Charles River (United States) Revenue: by Geography 2023
  • Figure 28. EVOTEC (Germany) Revenue, Net Income and Gross profit
  • Figure 29. EVOTEC (Germany) Revenue: by Geography 2023
  • Figure 30. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 31. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2023
  • Figure 32. GenScript, Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. GenScript, Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Oncodesign (France) Revenue, Net Income and Gross profit
  • Figure 37. Oncodesign (France) Revenue: by Geography 2023
  • Figure 38. Albany Molecular Research, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Albany Molecular Research, Inc. (United States) Revenue: by Geography 2023
  • Figure 40. Dalton Pharma Services (Canada) Revenue, Net Income and Gross profit
  • Figure 41. Dalton Pharma Services (Canada) Revenue: by Geography 2023
  • Figure 42. Pharmaceutical Product Development, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 43. Pharmaceutical Product Development, LLC (United States) Revenue: by Geography 2023
  • Figure 44. DiscoverX Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 45. DiscoverX Corporation (United States) Revenue: by Geography 2023
  • Figure 46. Bioduro LLC (United States) Revenue, Net Income and Gross profit
  • Figure 47. Bioduro LLC (United States) Revenue: by Geography 2023
  • Figure 48. Syngene International Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 49. Syngene International Ltd. (India) Revenue: by Geography 2023
  • Figure 50. Global Outsourced Drug Discovery: by Application USD Million (2025-2030)
  • Figure 51. Global Outsourced Drug Discovery: by Services USD Million (2025-2030)
  • Figure 52. Global Outsourced Drug Discovery: by Out sourcing Drug Type USD Million (2025-2030)
  • Figure 53. Global Outsourced Drug Discovery: by End-User USD Million (2025-2030)
  • Figure 54. South America Outsourced Drug Discovery Share (%), by Country
  • Figure 55. Asia Pacific Outsourced Drug Discovery Share (%), by Country
  • Figure 56. Europe Outsourced Drug Discovery Share (%), by Country
  • Figure 57. MEA Outsourced Drug Discovery Share (%), by Country
  • Figure 58. North America Outsourced Drug Discovery Share (%), by Country
  • Figure 59. Global Outsourced Drug Discovery: by Application K Tons (2025-2030)
  • Figure 60. Global Outsourced Drug Discovery: by Services K Tons (2025-2030)
  • Figure 61. Global Outsourced Drug Discovery: by Out sourcing Drug Type K Tons (2025-2030)
  • Figure 62. Global Outsourced Drug Discovery: by End-User K Tons (2025-2030)
  • Figure 63. South America Outsourced Drug Discovery Share (%), by Country
  • Figure 64. Asia Pacific Outsourced Drug Discovery Share (%), by Country
  • Figure 65. Europe Outsourced Drug Discovery Share (%), by Country
  • Figure 66. MEA Outsourced Drug Discovery Share (%), by Country
  • Figure 67. North America Outsourced Drug Discovery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Charles River (United States)
  • EVOTEC (Germany)
  • Laboratory Corporation of America Holdings (United States)
  • GenScript, Merck & Co., Inc. (United States)
  • Thermo Fisher Scientific, Inc. (United States)
  • Oncodesign (France)
  • Albany Molecular Research, Inc. (United States)
  • Dalton Pharma Services (Canada)
  • Pharmaceutical Product Development, LLC (United States)
  • DiscoverX Corporation (United States)
  • Bioduro LLC (United States)
  • Syngene International Ltd. (India)
Additional players considered in the study are as follows:
Sundia Meditech Co. Ltd. (China) , WuXi AppTec (China)
Select User Access Type

Key Highlights of Report


Apr 2024 246 Pages 80 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Outsourced Drug Discovery Quantitative research analysis
Global Outsourced Drug Discovery Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Outsourced Drug Discovery Market are by end use application [Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology and Others].
The Outsourced Drug Discovery Market is gaining popularity and expected to see strong valuation by 2030.
  • Growing Number of CRO, CMOs, and CDMOs in Emerging Countries
  • Rising Demand for the Biological Drugs

Know More About Global Outsourced Drug Discovery Report?

Have a Query? Click Here

Other Related Reports

Health Information Exchange Comprehensive Study by Type (Directed Exchange, Query-Based Exchange, Consumer Mediated Exchange), Application (Workflow Management, Secure Messaging, Internal Interfacing...
$ 3750
Cryotherapy Comprehensive Study by Type (Cryosurgery, Icepack Therapy, Chamber Therapy), Application (Pain Management, Surgical Application, Recovery, Health and Beauty), Device Used (Cryoguns, Cryo ...
$ 3650
Wound Management Disposable Comprehensive Study by Type (Cotton Swabs, Gauze, Wound Dressing, Other), Application (Emergency Care, Outpatient Facilities, Hospitals, Home Healthcare Facilities), Distr...
$ 3650
Penile Cancer Comprehensive Study by Diagnostic Test Type (Biopsy, Ultrasound, Imaging Tests (Computed Tomography (CT), Position Emission Tomography (PET), Magnetic Resonance Imaging (MRI))), Penile ...
$ 3750
Health Caregiving Comprehensive Study by Application (Home, Hospital, Wellness Centers, Other), Service (Physical Health, Psychological Health), End User (Children, Elders, Disabled, Others) Players ...
$ 3500
Alternative Medicines and Therapies Comprehensive Study by Type (Mud Therapy, Reiki, Oil Massage Therapy, Magnetic Therapy, Some Breathing Exercises, Meditation, Yoga, Osteopathic Manipulation), Appl...
$ 3650